United States · FDA National Drug Code directory
NALOXONE HCI
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 51662-1242_0ff862db-44cb-aac2-e063-6394a90a8a5d
- Product NDC
- 51662-1242
- Form
- INJECTION, SOLUTION
- Composition / generic term
- NALOXONE HCI
- Labeler
- HF Acquisition Co. LLC, DBA Health First
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20180818
- Source listing expiry
- 20261231
Source-listed ingredients
- NALOXONE HYDROCHLORIDE — .4 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 mL in 1 VIAL (51662-1242-1) · 51662-1242-1
- 50 POUCH in 1 CASE (51662-1242-3) / 1 mL in 1 POUCH (51662-1242-2) · 51662-1242-3
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →